Jinggong Hongyuan
1
19M
1
0.12
- Areas of investment
Summary
In 2016 was created Jinggong Hongyuan, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Beijing. The venture was found in Asia in China.
The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Jinggong Hongyuan, startups are often financed by General Technology Venture Capital. The meaningful sponsors for the fund in investment in the same round are ZGC Group, Shanghai Creation Investment, Proxima Ventures Ltd.
Among the various public portfolio startups of the fund, we may underline Cygnus Biosciences For fund there is a match between the location of its establishment and the land of its numerous investments - China. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Therapeutics.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.12
- Investments by industry
- Therapeutics (1)
- Biotechnology (1)
- Clinical Trials (1)
- Pharmaceutical (1)
- Health Diagnostics (1)
- Investments by region
-
- China (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 9
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cygnus Biosciences | 14 Nov 2017 | Biotechnology, Health Diagnostics, Pharmaceutical, Therapeutics, Clinical Trials | Early Stage Venture | 19M | Beijing, Changping District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.